risedronate sodium
Generic: risedronate sodium
Labeler: teva pharmaceuticals usa, inc.Drug Facts
Product Profile
Brand Name
risedronate sodium
Generic Name
risedronate sodium
Labeler
teva pharmaceuticals usa, inc.
Dosage Form
TABLET, FILM COATED
Routes
Active Ingredients
risedronate sodium monohydrate 5 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
0093-3099
Product ID
0093-3099_5495c43b-77b2-4ac7-b138-7cac84cca3ba
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA077132
Listing Expiration
2026-12-31
Marketing Start
2015-06-01
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
00933099
Hyphenated Format
0093-3099
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
risedronate sodium (source: ndc)
Generic Name
risedronate sodium (source: ndc)
Application Number
ANDA077132 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 5 mg/1
Packaging
- 30 TABLET, FILM COATED in 1 BOTTLE (0093-3099-56)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "5495c43b-77b2-4ac7-b138-7cac84cca3ba", "openfda": {"unii": ["F67L43UT5C"], "rxcui": ["905024", "905032", "905041", "905092", "905100"], "spl_set_id": ["dddcd321-4d2e-4643-bf3c-7b752b33ba39"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (0093-3099-56)", "package_ndc": "0093-3099-56", "marketing_start_date": "20150601"}], "brand_name": "Risedronate Sodium", "product_id": "0093-3099_5495c43b-77b2-4ac7-b138-7cac84cca3ba", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Bisphosphonate [EPC]", "Diphosphonates [CS]"], "product_ndc": "0093-3099", "generic_name": "Risedronate Sodium", "labeler_name": "Teva Pharmaceuticals USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Risedronate Sodium", "active_ingredients": [{"name": "RISEDRONATE SODIUM MONOHYDRATE", "strength": "5 mg/1"}], "application_number": "ANDA077132", "marketing_category": "ANDA", "marketing_start_date": "20150601", "listing_expiration_date": "20261231"}